Alpha-glucosidase inhibitor: approved for type 2 diabetes, longevity potential in animal models
MEMBERS ONLY
Continue Reading
This article is available to Vanguard members. Join to access all physician-curated content.
Acarbose
Alpha-glucosidase inhibitor: approved for type 2 diabetes, longevity potential in animal models